Company: WELNF
Filing Date: 2025-11-12
Form Type: DEFM14A
Source: 0001104659-25-109577
Chunk: 169

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-12
Form: DEFM14A
Chunk 169
---
 competitors during that period. In addition, while the Business Combination Agreement is in effect, each party is generally prohibited from soliciting, initiating, encouraging or entering into certain extraordinary transactions, such as a merger, sale of assets or other business combination outside the ordinary course of business, with any third party. Any such transactions could be favorable to such party’s shareholders or stockholders, respectively.

Third parties may terminate or alter existing contracts or relationships with IWAC or Btab.

IWAC and Btab have contracts with distributors, affiliates, landlords, licensors, and other business partners that may require IWAC or Btab, as applicable, to obtain consent from these other parties in connection with the Business Combination. If these consents cannot be obtained, the counterparties to these contracts and other third parties with which IWAC or Btab currently have relationships may have the ability to terminate, reduce the scope of, or otherwise materially adversely alter their relationships with either or both parties in anticipation of the Business Combination, or with Pubco following the Business Combination. The pursuit of such rights may result in IWAC, Btab, or Pubco suffering a loss of potential future revenue or incurring liabilities in connection with a breach of such agreements and losing rights that are material to its business. Any such disruptions could limit Pubco’s ability to achieve the anticipated benefits of the Business Combination. The adverse effect of such disruptions could also be exacerbated by a delay in the closing of the Business Combination or the termination of the Business Combination Agreement.

<div align='center'>66</div>

TABLE OF CONTENTS

Termination of the Business Combination Agreement could negatively impact IWAC and Btab.

If the Business Combination is not completed for any reason, including as a result of Btab stockholders declining to adopt the Business Combination Agreement and related proposals or IWAC shareholders declining to approve the proposals required to effect the Business Combination, the ongoing businesses of Btab and IWAC may be adversely impacted and, without realizing any of the anticipated benefits of completing the Business Combination, Btab and IWAC would be subject to a number of risks, including the following:

•

Btab or IWAC may experience negative reactions from the financial markets, and IWAC may experience a negative reaction to its stock price (including to the extent that current market prices reflect a market assumption that the Business Combination will be completed);

•

Btab may experience negative reactions from its users, vendors, and employees;

•

Btab and IWAC will have incurred substantial expenses and will be required to pay certain costs relating to the Business Combination